EI
TELA icon

EAM Investors’s TELA Bio TELA Stock Holding History

EAM Investors’s Portfolio TELA Stock Details TELA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-45,177
Closed -$585K – 352
2020
Q2 		$585K Buy
+45,177
New +$593K 0.13% 238

Other funds holding TELA

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return

EAM Investors's TELA Position: Q3 2020 in Review

EAM Investors sold out of TELA Bio (TELA) in Q3 2020, closing a stake of 45,177 shares — an estimated $585K sold.

EAM Investors first reported a position in TELA in Q2 2020 and held it in 1 quarter. The position peaked at $585K in Q2 2020. 44 funds tracked by Wall St. Rank hold TELA as of Q3 2020.

  • EAM Investors reported no remaining TELA Bio position as of Q3 2020 after selling out during the quarter.
  • EAM Investors sold 45,177 TELA Bio shares in Q3 2020, an estimated $585K.
  • EAM Investors first reported a position in TELA Bio in Q2 2020 and held it in 1 quarter.
  • EAM Investors's TELA Bio position peaked at $585K in Q2 2020.
  • 44 funds tracked by Wall St. Rank held TELA Bio as of Q3 2020.

Based on EAM Investors's 13F filing for Q3 2020, filed 13 Nov 2020.